16 results
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Evidence Summary of Major ... Trials - EGDT: NEJM ... - ProCESS: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
Murmurs Needing Echocardiography Evaluation #Management #EM #IM #Cardiology #Murmur #Benign #Characteristics #Echocardiogram #ALiEM
Evaluation #Management #EM ... #IM #Cardiology ... Echocardiogram #ALiEM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Major Clinical Trials ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... UGIB TRISS - NEJM ... /vmoitra) #EBM
Cardiac etiologies of syncope (red line above) have the highest associated mortality! #EBM #EM #IM #Cardiology
#EBM #EM #IM #Cardiology ... Cardiac #Mortality #ALiEM
Stroke Rate by CHADS2 Score (Gage et al., JAMA, 2001) https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607 #EBM #EM #IM #Cardiology #CHADS2
term=11401607 #EBM ... #EM #IM #Cardiology ... Score #StrokeRate #ALiEM
Phlegmasia Cerulea Dolens - In phlegmasia alba dolens, the thrombosis involves only major deep venous channels
involves only major ... #Clinical #EM #IM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM